Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Galaxy Digital Inc. Class A Common Stock (GLXY) vs Moderna, Inc. (MRNA) Price & Performance

Galaxy Digital Inc. Class A Common StockTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Galaxy Digital Inc. Class A Common Stock vs Moderna, Inc. — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.33 (market cap $3.90B), while Moderna, Inc. trades at $225 (market cap $78.65B). The key difference: Moderna, Inc. is far larger — about 20.2× Galaxy Digital Inc. Class A Common Stock's market cap, and Moderna, Inc. is trading nearer its 52-week high, Galaxy Digital Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 1 Days and Moderna, Inc. for 59 Days on average.

GLXYMRNA
Market Cap
$3.90B$78.65B
Volume
7,887,17337,373,437
Sector
FinancialsHealth
52-Week High
$42.86$203.46
52-Week Low
$16.84$22.36
Typical Hold Time
1 Days59 Days
Enterprise Value
$6.36B$74.80B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Galaxy Digital Inc. Class A Common Stock

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $197.00, up 0.26% on the day, with technical indicators showing a bullish trend and strong momentum. The stock has rallied over 500% in 2026, driven by positive clinical updates for its cancer vaccine pipeline and inclusion in the Nasdaq-100 index effective October 9, 2026. However, fundamentals remain challenging with revenue declining from $18.9B in 2022 to $1.9B in 2025 and negative net income margins exceeding 140%.

While technical momentum and pipeline optimism support near-term upside, valuation appears stretched with P/S of 35.08 and negative profitability metrics. Key risks include execution on non-COVID products, competitive pressure, and sustainability of recent gains. Analyst consensus is cautious with only 28% buy ratings and $115.70 price target suggesting significant downside from current levels.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GLXY

No sentiment data available yet.

MRNA
53% Buy47% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Galaxy Digital Inc. Class A Common Stock

Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.

Read more on GLXY →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA →